BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34054800)

  • 21. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
    Malo TL; Perkins RB; Lee JH; Vadaparampil ST
    Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].
    Phan DP; Pham QT; Strobel M; Tran DS; Tran TL; Buisson Y
    Rev Epidemiol Sante Publique; 2012 Dec; 60(6):437-46. PubMed ID: 23137871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
    Batmunkh T; Dalmau MT; Munkhsaikhan ME; Khorolsuren T; Namjil N; Surenjav U; Toh ZQ; Licciardi PV; Russell FM; Garland SM; Mulholland K; von Mollendorf C
    Vaccine; 2020 Jun; 38(27):4316-4324. PubMed ID: 32387009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine.
    Kreimer AR; Rodriguez AC; Hildesheim A; Herrero R; Porras C; Schiffman M; González P; Solomon D; Jiménez S; Schiller JT; Lowy DR; Quint W; Sherman ME; Schussler J; Wacholder S;
    J Natl Cancer Inst; 2011 Oct; 103(19):1444-51. PubMed ID: 21908768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge, attitudes, and practices towards HPV vaccination among reproductive age women in a HIV hotspot in the US.
    Villavicencio A; Kelsey G; Nogueira NF; Zukerberg J; Salazar AS; Hernandez L; Raccamarich P; Alcaide ML
    PLoS One; 2023; 18(1):e0275141. PubMed ID: 36656804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
    Gomez JA; Lepetic A; Demarteau N
    BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): study protocol of a randomised controlled trial.
    Okunade KS; Adejimi AA; Adekanye TV; Allsop MJ; Adelabu H; Thomas-Ogodo O; Onyeka TC; Lawanson T; Akaba GO; Salako O; Anorlu RI; Berek JS
    BMC Cancer; 2024 Jun; 24(1):751. PubMed ID: 38902718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The recording of human papillomavirus (HPV) vaccination in BIFAP primary care database: A validation study.
    Martín-Merino E; Llorente-García A; Montero-Corominas D; Huerta C
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):201-208. PubMed ID: 30488510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of an Inpatient Postpartum Human Papillomavirus Immunization Program.
    Avni-Singer L; Oliveira CR; Torres A; Shapiro ED; Niccolai LM; Sheth SS
    Obstet Gynecol; 2020 Nov; 136(5):1006-1015. PubMed ID: 33030866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catch-up HPV Vaccination and Subsequent Uptake of Papanicolaou Testing in A State-mandated Health System.
    Chodick G; Leader AE; Larson S
    Cancer Prev Res (Phila); 2021 Apr; 14(4):415-420. PubMed ID: 33687944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Female students receiving post-secondary education in Greece: the results of a collaborative human papillomavirus knowledge survey.
    Michail G; Smaili M; Vozikis A; Jelastopulu E; Adonakis G; Poulas K
    Public Health; 2014 Dec; 128(12):1099-105. PubMed ID: 25443133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia.
    Brotherton JM; Mullins RM
    Cancer Epidemiol; 2012 Jun; 36(3):298-302. PubMed ID: 22204834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between prior HPV4 vaccine doses and cervical cancer screening participation.
    Boone SD; Pinkston CM; Baumgartner KB; Baumgartner RN; Harper SM; Bonham AJ; Paynter CA; Harper DM
    Cancer Epidemiol; 2016 Jun; 42():108-14. PubMed ID: 27100836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs.
    Markowitz LE; Drolet M; Perez N; Jit M; Brisson M
    Vaccine; 2018 Aug; 36(32 Pt A):4806-4815. PubMed ID: 29802000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study.
    Silverberg MJ; Leyden WA; Lam JO; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF
    Lancet Child Adolesc Health; 2018 Oct; 2(10):707-714. PubMed ID: 30236379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval.
    Martín-Merino E; Llorente-García A; Castillo Cano B; Montero Corominas D; Huerta-Álvarez C
    Pharmaceut Med; 2019 Dec; 33(6):519-530. PubMed ID: 31933243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytology and DNA HPV-testing in the era of HPV-vaccine].
    Spaczyński M; Malkowska-Walczak B; Nowak-Markwitz E
    Ginekol Pol; 2007 Sep; 78(9):696-700. PubMed ID: 18159823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
    Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
    Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potential missed opportunities for human papillomavirus (HPV) vaccination in women referred to an academic colposcopy clinic for evaluation of abnormal cervical cytology.
    Dorton BJ; Vitonis AF; Feldman S
    Hum Vaccin Immunother; 2016 Jun; 12(6):1639-45. PubMed ID: 26839185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.